Fertility in patients with congenital adrenal hyperplasia

Journal of Pediatric Endocrinology and Metabolism

Volumn 19, Issue 5, 2006, Pages 677-685

  Claahsen van der Grinten, H L ^a   Stikkelbroeck, N M M L ^a   Sweep, C G J ^a   Hermus, A R M M ^a   Otten, B J ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Congenital adrenal hyperplasia; Fertility

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; CORTICOTROPIN; ESTRONE; FOLLITROPIN; GESTAGEN; GLUCOCORTICOID; HYDROXYPROGESTERONE; INHIBIN B; PROGESTERONE; TESTOSTERONE;

ADRENAL SUPPRESSION; CONGENITAL ADRENAL HYPERPLASIA; DRUG TREATMENT FAILURE; FEMALE INFERTILITY; FOLLITROPIN BLOOD LEVEL; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; LONG TERM CARE; MALE INFERTILITY; MENARCHE; MENSTRUAL CYCLE; OVARY CYCLE; OVARY POLYCYSTIC DISEASE; OVARY TUMOR; PHENOTYPE; PREGNANCY RATE; PSYCHOLOGICAL ASPECT; PUBERTY; REVIEW; SALT LOSING NEPHRITIS; SEMEN ANALYSIS; SEXUALITY; SUBFERTILITY; TESTIS TUMOR; UNSPECIFIED SIDE EFFECT;

EID: 33745234141     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.2006.19.5.677     Document Type: Review

References (75)

1. White PC, Speiser PW. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr Rev 2000; 21: 245-291.
2. Jaaskelainen J, Kiekara O, Hippelainen M, Voutilainen R. Pituitary gonadal axis and child rate in males with classical 21-hydroxylase deficiency. J Endocrinol Invest 2000; 23: 23-27.
3. Urban MD, Lee PA, Migeon CJ. Adult height and fertility in men with congenital virilizing adrenal hyperplasia. N Engl J Med 1978; 299: 1392-1396.
4. Wuesthof AR, Willig RP, Schulze W, Hoepffner W, Knorr D, Schwarz HP. Spermatogenesis is impaired in men with congenital adrenal hyperplasia. Horm Res 1998; 50: 104-104.
5. Cabrera MS, Vogiatzi MG, New MI. Long term outcome in adult males with classic congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001; 86: 3070-3078.
6. Stikkelbroeck NMML, Otten BJ, Pasic A, Jager GJ, Sweep CGJ, Noordam K, Hermus ARMM. High prevalence of testicular adrenal rest tumours, impaired spermatogenesis, and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001; 86: 5721-5728.
7. Clark RV, Albertson BD, Munabi A, Cassorla F, Aguilera G, Warren DW, Sherins RJ, Loriaux DL. Steroidogenic enzyme activities, morphology and receptor studies of a testicular adrenal rest in a patient with congenital adrenal hyperplasia. J Clin Endocrinol Metab 1990; 70: 1408-1413.
8. Johnson RE, Scheithauer B. Massive hyperplasia of testicular adrenal rests in a patient with Nelson's syndrome. Am J Pathol 1982; 77: 501-507.
9. Seidenwurm D, Smathers RL, Kan P, Hoffman A. Intratesticular adrenal rests diagnosed by ultrasound. Radiology 2004; 14: 1802-1806.
10. Avila NA, Premkumar A, Shawker TH, Jones JV, Laue L, Cutler GB. Testicular adrenal rest tissue in congenital adrenal hyperplasia: Findings at gray-scale and colour Doppler US. Radiology 1996; 198: 99-104.
11. Avila NA, Premkumar A, Merke DP. Testicular adrenal rest tissue in congenital adrenal hyperplasia: comparison of MR imaging and sonographic findings. Am J Roentgenol 1999; 172: 1003-1006.
12. Stikkelbroeck NMML, Suliman HM, Otten BJ, Hermus ARMM, Blickman J, Jager GJ. Testicular adrenal rest tumours in postpubertal males with congenital adrenal hyperplasia: sonographic and MR features. Eur Radiol 2003; 13: 1603.
13. Shanklin DR, Richardson AP Jr, Rothstein G. Testicular hilar nodules in adrenogenital syndrome. Am J Dis Child 1963; 106: 243-250.
14. Rich MA, Keating MA, Levin HS, Kay R. Tumours of the adrenogenital syndrome: an aggressive conservative approach. J Urol 1998; 160: 1838-1841.
15. Murphy H, George C, de Kretser DD, Judd S. Successful treatment with ICSI of infertility caused by azoospermia associated with adrenal rests in the testes: case report. Hum Reprod 2001; 16: 263-267.
16. Otten BJ, Stikkelbroeck MML, Hermus ARMM. Hypogonadism in males with congenital adrenal hyperplasia. In: Winters SJ, ed. Male Hypogonadism: Basic, Clinical and Therapeutic Principles. Totowa, NJ: Humana Press, 2004; 125-137.
17. Moore GW, Lacroix A, Rabin D, McKenna TJ. Gonadal dysfunction in adult men with congenital adrenal hyperplasia. Acta Endocrinol (Copenh) 1980; 95: 185-193.
18. Bonaccorsi AC, Adler I, Figueiredo JG. Male infertility due to congenital adrenal hyperplasia: testicular biopsy findings, hormonal evaluation, and therapeutic results in three patients. Fertil Steril 1987; 47: 664-670.
19. Merke DP, Bornstein SR, Avila NA, Chrousos GP. NIH conference. Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Ann Intern Med 2002; 136: 320-334.
20. Giacaglia LR, Mendonca BB, Madureira G, Melo KFF, Suslik CA, Arnhold IJP, Bacheca ASS. Adrenal nodules in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: regression after adequate hormonal control. J Pediatr Endocrinol Metab 2001; 14: 415-419.
21. Rutgers JL, Young RH, Scully RE. The testicular tumour of the adrenogenital syndrome. A report of six cases and review of the literature on testicular masses in patients with adrenocortical disorders. Am J Surg Pathol 1988; 12: 503-513.
22. Walker BR, Skoog SJ, Winslow BH, Canning DA, Tank ES. Testis sparing surgery for steroid unresponsive testicular tumours of the adrenogenital syndrome. J Urol 1997; 157: 1460-1463.
23. Stikkelbroeck NML, Hermus ARMM, Suliman HM, Jager GJ, Otten BJ. Asymptomatic testicular adrenal rest tumours in adolescent and adult males with congenital adrenal hyperplasia: basal and follow-up investigation after 2.6 years. J Pediatr Endocrinol Metab 2004; 17: 645-653.
24. Battaglia M, Di Tonno P, Palazzo S, Bettocchi C, Selvaggio O, Garofano L, Selvaggi FP. Bilateral tumours of the testis in 21 hydroxylase deficiency without adrenal hyperplasia. Urol Oncol 2005; 23: 178-180.
25. Tiryaki T, Aycan Z, Huecumenglu S. Testis sparing surgery for steroid unresponsive testicular tumors of the congenital adrenal hyperplasia. Pedia Surg Int 2005; 21: 853-855.
26. Davis JM, Woodroof J, Sadasivan R, Stephens R. Case report: congenital adrenal hyperplasia and malignant Leydig cell tumour. Am J Med Sci 1995; 309: 63-65.
27. Molitor JT, Chertow BS, Fariss BL. Long-term follow-up of a patient with congenital adrenal hyperplasia and failure of testicular development. Fertil Steril 1973; 24: 319-323.
28. Tiitinen A, Valimaki M. Primary infertility in a 45-year old man with untreated 21-hydroxylase deficiency: successful outcome with glucocorticoid therapy. J Clin Endocrinol Metab 2002; 87: 2442-2445.
29. Kalachanis I, Rousso D, Kourtis A, Goutzioulis F, Makedos G, Panidis D. Reversible infertility, pharmaceutical and spontaneous, in a male with late onset congenital adrenal hyperplasia, due to 21-hydroxylase deficiency. Arch Androl 2002; 48: 37-41.
30. Stikkelbroeck NMML, Hermus ARMM, Braat DDM, Otten BJ. Fertility in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Obstet Gynaecol Surv 2003; 58: 45-284.
31. Dumic M, Janjanin N, Ille J, Zunec R, Spehar A, Zlopasa G, Francetic I, New MI. Pregnancy outcomes in women with classical adrenal hyperplasia due to 21-hydroxylase deficiency. J Pediatr Endocrinol Metab 2005; 18: 887-895.
32. Mulaikal RM, Migeon CJ, Rock JA. Fertility rates in female patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N Engl J Med 1987; 316: 178-182.
33. Hoepffner W, Schulze E, Bennek J, Keller E, Ewillgerodt H. Pregnancies in patients with congenital adrenal hyperplasia with complete or almost complete impairment of 21-hydroxylase deficiency. Fertil Steril 2004; 81: 1314-1320.
34. Helleday J, Siwers B, Ritzen EM, Carlstrom K. Subnormal androgen and elevated progesterone levels in women treated for congenital virilizing 21-hydroxylase deficiency. J Clin Endocrinol Metab 1993; 76: 933-936.
35. Jaaskelainen J, Hippelainen M, Kiekara O, Voutilainen R. Child rate, pregnancy outcome and ovarian function in females with classical 21-hydroxylase deficiency. Acta Obstet Gynecol Scand 2000; 79: 687-692.
36. Krone N, Wachter I, Stefanidou M, Roscher AA, Schwarz HP. Mothers with congenital adrenal hyperplasia and their children: outcome of pregnancy, birth and childhood. Clin Endocrinol (Oxf) 2001; 55: 523-529.
37. Lo JC, Grumbach MM. Pregnancy outcomes in women with congenital virilizing adrenal hyperplasia. Endocrinol Metab Clin North Am 2001; 30: 207-229, IX.
38. - sex-specific gene in neonatal screening for congenital adrenal hyperplasia. J Clin Endocrinol Metab 1999; 84: 960-966.
39. Birnbaum MD, Rose LI. Late onset adrenocortical hydroxylase deficiency associated with menstrual dysfunction. Obstet Gynecol 1984; 63: 445-451.
40. Feldman S, Billaud L, Thalabard JC, Raux-Demay MC, Mowszowicz I, Kuttenn F, Mauvais-Jarvis P. Fertility in women with late-onset adrenal hyperplasia due to 21-hydroxylase deficiency. J Clin Endocrinol Metab 1992; 74: 635-639.
41. Holmes-Walker DJ, Conway GS, Honour JW. Menstrual disturbance and hypersecretion of progesterone in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Clin Endocrinol (Oxf) 1995; 43: 291-296.
42. Hagenfeldt K, Ritzen EM, Ringertz H, Helleday J, Carlstrom K. Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocorticoid treatment since infancy. Eur J Endocrinol 2000; 143: 667-671.
43. Rosenfield RL, Bickel S, Razdan AK Amenorrhea related to progestin excess in congenital adrenal hyperplasia. Obstet Gynecol 1980; 56: 208-215.
44. Riad-Fahmy D, Read GF, Walker RF, Griffithset K. Steroids in saliva for assessing endocrine function. Endocr Rev 1982; 3: 367-395.
45. Speroff L, Glass RH, Kase NG, eds. Clinical Gynecologic Endocrinology and Infertility, 6th Ed. Maryland: Lippincott Williams & Wilkins, 1999.
46. Richards GE, Grumbach MM, Kaplan SL, Conte FA. The effect of long acting glucocorticoids on menstrual abnormalities in patients with virilizing congenital adrenal hyperplasia. J Clin Endocrinol Metab 1978; 47: 1208-1215.
47. Bruining H, Bootsma AH, Koper JW, Bonjer J, de Jong FH, Lamberts SWJ. Fertility and body composition after laparoscopic bilateral adrenalectomy in a 30-year-old female with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2001; 86: 482-484.
48. Ehrmann DA, Barnes RB, Rosenfield RL. Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion. Endocr Rev 1995; 16: 322-353.
49. Saygili F, Oge A, Yilmaz C. Hyperinsulinemia and insulin insensitivity in women with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency: the relationship between serum leptin levels and chronic hyperinsulinemia. Horm Res 2005; 63: 270-274.
50. Charmandari E, Weise M, Bornstein SR, Eisenhofer G, Keil MF, Chrousos GP, Merke DP. Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical implications. J Clin Endocrinol Metab 2002; 87: 2114-2120.
51. Barnes RB, Rosenfield RL, Ehrmann DA. Ovarian hyperandrogenism as a result of congenital adrenal virilizing disorders: evidence of perinatal masculinization of neuroendocrine function in women. J Clin Endocrinol Metab 1994; 79: 1328-1333.
52. Yarman S. Dursun A. Oguz F, Alagoel F. The prevalence, molecular analysis and HLA typing of late onset 21-hydroxylase deficiency in Turkish women with hirsutism and polycystic ovary. Endocr J 2004; 51: 31-36.
53. Kamel N, Tonyukuk V, Emral R., Copapcioglu D, Bastemir M, Guellue S. The prevalence of late onset congenital adrenal hyperplasia in hirsute women from central Anatolia. Endocr J 2003; 50: 815-823.
54. Kousta E, White DM, Cela E, McCarthy MI, Frabks S. The prevalence of polycystic ovaries in women with infertility. Hum Reprod 1999; 14: 2720-2723.
55. Jaaskelainen J, Tiitinen A, Voutilainen R Sexual function and fertility in adult females and males with congenital adrenal hyperplasia. Horm Res 2001; 56: 73-80.
56. Stikkelbroeck NMML, Hermus ARMM, Schouten D, Suliman HM, Jager GJ, Braat DDM, Otten BJ. Prevalence of ovarian adrenal rest tumours and polycystic ovaries in females with congenital adrenal hyperplasia: results of ultrasonography and MR imaging. Eur Radiol 2004; 14: 1802-1806.
57. Al-Ahmadie HA, Stanek J, Liu J, Mangu PN, Niemann T, Young RH. Ovarian 'tumour' of the adrenogenital syndrome - the first reported case. Am J Surg Pathol 2001; 25: 1443-1450.
58. Russo G, Paesano P, Taccagni G, Del Maschio A, Chiumello G. Ovarian adrenal-like tissue in congenital adrenal hyperplasia [Letter]. N Engl J Med 1998; 339: 853-854.
59. Claahsen-van der Grinten HL, Hulsbergen-van de Kaa CA, Otten BJ. Ovarian adrenal rest tissue in congenital adrenal hyperplasia - a case report. J Pediatr Endocrinol Metab 2006; 19: 177-182.
60. Farkas A, Chertin B. Feminizing genitoplasty in patients with 46,XX congenital adrenal hyperplasia. J Pediatr Endocrinol Metab 2001; 14: 713-722.
61. Clayton PE, Miller WL, Oberfield SE, Ritzen EM, Sippell WG, Speiser PW. Consensus statement on 21-hydroxylase deficiency from the European Society of Paediatric Endocrinology and the Lawson Wilkins Paediatric Endocrinology Society. Horm Res 2002; 58: 188.
62. Crouch NS, Minto CL, Laio LM, Woodhouse CRJ, Creighton SM. Genital sensation after feminizing genitoplasty for congenital adrenal hyperplasia: a pilot study. BJU Int 2004; 93: 135-138.
63. Eroglu E, Guendoglu G, Emir H, Ercan O, Soeylet Y, Danigmend N. Feminizing surgical management of intersex patients. Pediatr Surg Int 2004; 20: 543-547.
64. Al-Bassam A, Gado A. Feminizing genital reconstruction: experience with 52 cases of ambiguous genitalia. Eur J Pediatr Surg 2004; 14:172-178.
65. Sotiropoulos A, Morishima A, Homsy Y, Lattimer JK. Long-term assessment of genital reconstruction in female pseudohermaphrodites. J Urol 1976; 115: 599-601.
66. Krege S, Walz KH, Hauffa BP, Koerner I, Ruebben H. Long-term follow-up of female patients with congenital adrenal hyperplasia from 21-hydroxylase deficiency, with special emphasis on the results of vaginoplasty. BJU Int 2000; 86: 253-259.
67. Slijper FM, Drop SLS, Molenaar JC, de Muinck Keizer-Schrama SMPF. Long-term psychological evaluation of intersex children. Arch Sex Behav 1998; 27: 125-144.
68. Hines M, Brook C, Conway GS. Androgen and psychosexual development: core gender identity, sexual orientation and recalled childhood gender role behaviour in women and men with congenital adrenal hyperplasia. J Sex Res 2004; 41: 75-81.
69. Meyer-Bahlburg HFL. What causes how rates of childbearing in congenital adrenal hyperplasia? J Clin Endocrinol Metab 1999; 84: 1844-1847.
70. Wisniewski AB, Mignon CJ, Malouf MA, Gearhart JP. Psychosexual outcome in women affected by congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Urol 2004; 171: 2497-2501.
71. Noordenstrom A, Servin A, Bohlin G, Larsson A, Wedell A. Sex-typed toy play behaviour correlates with the degree of prenatal androgen exposure assessed by CYP21 genotype in girls with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2002; 87: 5119-5124.
72. Hall CM, Jones JA, Meyer-Bahlburg HFL, Dolezal C, Coleman M, Foster P, Price DA, Clayton PA. Behavioral and physical masculinization are related to genotype in girls with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2004; 89: 419-424.
73. Berenbaum SA, Bailey JM. Effects on gender identity of prenatal androgens and genital appearance: evidence from girls with congenital adrenal hyperplasia. J Clin Endocrinol Metab 2003; 88: 1102-1106.
74. Brook HM, Conway GS. Androgen and psychosexual development: core gender identity, sexual orientation and recalled childhood gender role behaviour in women and men with congenital adrenal hyperplasia. J Sex Res 2004; 41: 75-81.
75. Long DN, Wisniewsky AB, Migeon CJ. Gender role across development in adult women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Pediatr Endocrinol Metab 2004; 17: 1357-1373.